This inventor holds 1 USPTO granted patent. Top assignee: Koninklijke Philips Corporation N.v.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovations of Sitharthan Kalalakaran
Introduction
Sitharthan Kalalakaran is an accomplished inventor based in Pelham, NY (US). He has made significant contributions to the field of genetic diagnostics. His work focuses on the relevance of genetic variants in relation to specific diseases, which has important implications for personalized medicine.
Latest Patents
Sitharthan holds a patent titled "Diagnostic genetic analysis using variant-disease association with patient-specific relevance assessment." This patent describes a method for assessing the relevance of a genetic variant observed in diagnostic subject genetic data. The process involves identifying a set of polymorphisms functionally related to the study genetic variant. A foreground distribution of variants is computed from the diagnostic subject's genetic data, while a background distribution is derived from the genetic data of subjects in a clinical study. A comparison metric is then calculated to quantify the relevance of the study variant to the diagnostic subject, with higher similarity between the distributions indicating greater relevance. He has 1 patent to his name.
Career Highlights
Sitharthan is currently employed at Koninklijke Philips Corporation N.V., where he continues to innovate in the field of genetic diagnostics. His work is pivotal in advancing the understanding of genetic variants and their associations with diseases.
Collaborations
Sitharthan collaborates with notable colleagues, including Vinay Varadan and Nilanjana Banerjee. Their combined expertise contributes to the development of cutting-edge solutions in genetic analysis.
Conclusion
Sitharthan Kalalakaran's contributions to genetic diagnostics exemplify the importance of innovation in healthcare. His work not only enhances our understanding of genetic variants but also paves the way for more personalized approaches to medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
